PharmCo III ApS: Financial statements 2020
CVR: 41103647
Source: annual report 2020, Danish Business Authority
23/01/2020 – 31/12/2020
PharmCo III ApS (CVR 41103647) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -35,000 and a net result of DKK 18,571,189. Equity in the 2020 report amounted to DKK 18,167,506. The solvency ratio was 21.5%.
- Gross Profit
- DKK -35,000
- Profit/Loss
- DKK 18,571,189
- Equity
- DKK 18,167,506
- Total Assets
- DKK 84,405,138
Official annual report
How creditworthy is PharmCo III ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of January 23, 2020, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PharmCo III ApS.
As of January 23, 2020, Eli Wallin is registered as director of PharmCo III ApS.
As of January 23, 2020, Eli Wallin is registered as an owner of PharmCo III ApS with an ownership share of 100%.
PharmCo III ApS was founded on January 23, 2020.
About PharmCo III ApS
PharmCo III ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -33,000 and a net result of DKK 18,532,000 compared with DKK 13,877,698 the year before. Equity in the 2025 report amounted to DKK 100,696,000.